OR WAIT null SECS
July 02, 2023
A novel complement therapeutic CTx001 offers a novel approach to treating geographic atrophy.
June 29, 2023
Tower Cold Chain will soon open its new headquarters in Philadelphia.
This arrangement was approved by the shareholders at BELLUS on June 16, 2023, according to a company press release.
June 26, 2023
This collaboration is the first commercialization into the United States and Canadian markets for Rio Biopharmaceuticals.
June 23, 2023
Sanofi’s Open Innovation Portal is designed to promote community feedback and propose novel solutions to various problems in the healthcare landscape.
Sandbox AQ’s molecular simulation division is collaborating with companies like AstraZeneca and Sanofi to develop novel treatments for various disorders.
June 20, 2023
The transaction is expected to close in the third quarter of 2023.
Eli Lilly & Company will pay Verve Therapeutics up to $525 million to advance a lipoprotein gene editing research program.
June 15, 2023
The collaboration between the Pistoia Alliance and Matador Japan will work to accelerate research and promote access to a global pharmaceutical ecosystem.
The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.